This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.
Eligibility
Sex
ALL
Min age
1 Month
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria:
1. aged 1 month-18 years old (date of investigate minus date of birth)
2. epilepsy
3. intracranial tumors
4. cerebrovascular diseases
5. autism
6. mental retardation
7. ADHD
8. tic disorder
9. neuropsychiatric disorders
Exclusion Criteria:
1.Unable to cooperate with the exam of MEG
Primary outcome measure(s)
Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children — 3 years Acquisition of magnetoencephalography (MEG) signals based on Inclusion Criteria
Trial sites (1)
Facility
City
Region
Status
Children's Hospital of Fudan University
Shanghai
China
Recruiting
More Children's Hospital of Fudan University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.